We are live on ! Find out more
HGEN

HUMANIGEN, INC.

Delisted

HGEN was delisted on the 25th of July, 2023.

38 hedge funds and large institutions have $841K invested in HUMANIGEN, INC. in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $669K → $841K (+$172K)

10% less funds holding

Funds holding: 4238 (-4)

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
38
Holders Change
-4
Holders Change %
-9.52%
% of All Funds
0.6%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
7
Reduced
10
Closed
6
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
-$1K

HGEN Hedge Fund Activity: Q2 2023 in Review

38 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q2 2023, worth a combined $841K — up 26% from $669K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of HGEN and 2 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 7 added.

The largest buyer was Vanguard Group, adding an estimated $157K. The largest seller was UBS Group, cutting an estimated $50K.

  • 38 institutional investors held HUMANIGEN, INC. (HGEN) as of Q2 2023, down from 42 in Q1 2023.
  • Funds reported $841K of HUMANIGEN, INC. stock for Q2 2023, up 26% quarter-over-quarter.
  • 2 funds opened new HUMANIGEN, INC. positions in Q2 2023 and 6 closed out, a net change of -4 holders.
  • The largest HUMANIGEN, INC. buyer in Q2 2023 was Vanguard Group, an estimated $157K added.
  • The largest HUMANIGEN, INC. seller in Q2 2023 was UBS Group, an estimated $50K sold.

Based on aggregated 13F filings for Q2 2023.